Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication

Journal of Virology

Volumn 76, Issue 13, 2002, Pages 6558-6567

  Härle, Peter ^a   Cull, Vanessa ^a   Agbaga, Martin Paul ^a   Silverman, Robert ^a   Williams, Bryan R G ^a   James, Cassandra ^a   Carr, Daniel J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA1 INTERFERON; ALPHA4 INTERFERON; ALPHA5 INTERFERON; ALPHA6 INTERFERON; ALPHA9 INTERFERON; BETA INTERFERON; CELL PROTEIN; CELL PROTEIN 27; GLYCOPROTEIN B; PLASMID VECTOR; PROTEIN KINASE; PROTEIN KINASE R; STAT1 PROTEIN; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BIOASSAY; CELL STRAIN L 929; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; DISEASE COURSE; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENETIC TRANSFECTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNOTHERAPY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; TRANSGENE; VIRUS INDUCTION; VIRUS INHIBITION; VIRUS TITRATION;

ANIMALS; CELL LINE; EIF-2 KINASE; HERPESVIRUS 1, HUMAN; INTERFERON-ALPHA; INTERFERON-BETA; MICE; TRANSFECTION; TRANSGENES; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 0036281763     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.13.6558-6567.2002     Document Type: Article

References (75)

1. In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis
2. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47
3. Dissociation between IFN-α-induced anti-viral and growth signaling pathways
4. Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway
5. Relative antiviral activity of in vitro-synthesized murine interferon-α4 and -α1
6. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1
7. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1
8. 134.5 protein of herpes simplex virus 1 are required for viral resistance to interferon-α/β
9. - mutants of herpes simplex virus 1
10. Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis
11. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
12. Identification of genes differentially regulated by interferon α, β, and γ using oligonucleotide arrays
13. Specific effect of interferon on the herpes simplex virus type 1 transactivation event
14. Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease
15. Experimental infection of inbred mice with herpes simplex virus. II. Interferon production and activation of natural killer cells in the peritoneal exudate
16. Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virus
17. Glycoprotein C of herpes simplex virus type 1 acts as a receptor for the C3b complement component on infected cells
18. Configuration of the interferon-α/β receptor complex determines the context of the biological response
19. + T cell response
20. Noncytolytic control of viral infections by the innate and adaptive immune repsonse
21. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1
22. Innate and acquired immunity to herpes simplex virus type 1
23. Expression of human and macaque type I IFN transgenes interfere with HSV-1 replication at the transcriptional and translational level: IFN-β is more potent than IFN-α2
24. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-α/β
25. 134.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1 alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase
26. Endogenously produced interferon α protects mice from herpes simplex virus type 1 corneal disease
27. The role of macrophages and macrophage cytokines in the host resistance to herpes simplex virus
28. Herpes simplex virus turns off the TAP to evade host immunity
29. Divergence of binding, signaling, and biological responses to recombinant human hybrid IFN
30. 2-terminal kinase by double-stranded RNA and encephalomyocarditis virus: Involvement of RNase L, protein kinase R, and alternative pathways
31. Herpes simplex virus type 1 induces apoptosis in peripheral blood T lymphocytes
32. Effect of herpes simplex virus types 1 and 2 on surface expression of class I major histocompatibility complex antigens on infected cells
33. Herpes simplex virus renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis
34. Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3
35. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes
36. Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system
37. TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression
38. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo
39. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene
40. Restricted replication of herpes simplex virus in human monocyte cultures: Role of interferon
41. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection
42. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse models
43. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7
44. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses
45. 1 production in human cells by herpes simplex virus
46. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon
47. Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription
48. The type I interferon receptor: Structure, function, and evolution of a family business
49. Herpes simplex virus ICP0 mutants are hypersensitive to interferon
50. Formation of non-infective herpesvirus particles in cultured cells treated with human interferon
51. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor
52. Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific
53. Mechanism for discrimination between viral and host mRNA in interferon-treated cells
54. The human interferon alpha/beta receptor: Characterization and molecular cloning
55. Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway
56. Herpes simplex virus type 1 infection of activated cytotoxic T cells: Induction of fratricide as a mechanism of viral immune evasion
57. Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis
58. Antiviral activity of autocrine interferon-beta requires the presence of a functional interferon type I receptor
59. Antiviral action of interferon. Interferon-regulated cellular proteins and their surprisingly selective antiviral activities
60. Participation of type I interferon in the decreased virulence of the UL13 gene-deleted mutant of herpes simplex virus type 1
61. Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1
62. Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1
63. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions
64. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: Implications for the fate of virally infected neurons
65. Synthesis of herpes simplex virus proteins and nucleic acids in interferon-treated macrophages
66. Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/ beta interferon
67. Mapping the genetic region coding for herpes simplex virus resistance to mouse interferon-α/β
68. Biological activities of recombinant murine interferons alpha 1 and alpha 4: Large difference in antiproliferative effect
69. The emerging role of the interferoninduced PKR protein kinase as an apoptotic effector: A new face of death?
70. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP
71. Neutrophilmediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea
72. Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation
73. Antiviral activities of individual murine interferon alpha subtypes in vivo: Intramuscular injection of interferon expression constructs reduces cytomegalovirus replication
74. Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and Janus kinases during an early infection stage
75. Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylateependent RNase L